Published on in Vol 7 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/46179, first published .
m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study

m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study

m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study

Eva Grasa   1, 2 , PhD ;   Jussi Seppälä   3, 4 , MD, PhD ;   Anna Alonso-Solis   2, 5 , PhD ;   Marianne Haapea   4, 6, 7 , PhD ;   Matti Isohanni   4 , MD, PhD ;   Jouko Miettunen   4, 6 , PhD ;   Johanna Caro Mendivelso   8 , MD, PhD ;   Cari Almazan   8 , MD ;   Katya Rubinstein   9 , PhD ;   Asaf Caspi   9 , MD ;   Zsolt Unoka   10 , MD ;   Kinga Farkas   10 , MD, PhD ;   Judith Usall   2, 11, 12 , MD, PhD ;   Susana Ochoa   2, 11, 12 , PhD ;   Shenja van der Graaf   13 , PhD ;   Charlotte Jewell   14 , MSc ;   Anna Triantafillou   15 , MA ;   Matthias Stevens   16, 17 , PhD ;   Elisenda Reixach   18 , PhD ;   Jesus Berdun   19 , MSc ;   m-RESIST group   20 ;   Iluminada Corripio   2, 21 , MD, PhD

1 Mental Health, Institut d’Investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain

2 Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III, Madrid, Spain

3 Social Insurance Institution of Finland, Kuopio, Finland

4 Research Unit of Population Health, University of Oulu, Oulu, Finland

5 Mental Health Division, Fundació Althaia, Xarxa Assistencial Universitaria de Manresa, Manresa, Spain

6 Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland

7 Department of Psychiatry, Oulu University Hospital, Oulu, Finland

8 Agency for Health Quality and Assessment of Catalonia (AQuAS), Barcelona, Spain

9 The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Tel-Aviv University, Tel-Aviv, Israel

10 Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary

11 Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain

12 Etiopatogènia i tractament dels trastorns mentals greus (MERITT), Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain

13 Department of Communication Science, University of Twente, Twente, Netherlands

14 Lentic-CRIS, University of Liège, Liège, Belgium

15 Athens Technology Center, Athens, Greece

16 EDiT Department, imec, Ghent/Antwerp, Belgium

17 Solutions Department, imec, Leuven, Belgium

18 TicSalut Health Department, Generalitat de Catalunya, Barcelona, Spain

19 Digital Health Unit, Hospital de la Santa Creu i Sant Pau, Institut d’Investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain

20 see Authors' Contributions, Barcelona, Spain

21 Mental Health and Psychiatry Department, Vic Hospital Consortium, Vic, Spain

Corresponding Author:

  • Anna Alonso-Solis, PhD
  • Mental Health Division
  • Fundació Althaia
  • Xarxa Assistencial Universitaria de Manresa
  • Llatjos St
  • Manresa, 08243
  • Spain
  • Phone: 34 93 8742112
  • Email: aalonso@althaia.cat